KIM
48
10
ABT
48
-2
VRSK
89
5
GPS
63
4
TSN
30
3
ZION
44
3
PGR
69
5
BAX
35
2
TAP
31
2
BA
44
2
AAL
20
2
ES
33
-5
KSS
38
2
QCOM
82
3
CF
36
3
SYF
67
2
SRE
28
-5
TDC
55
-2
SWKS
60
-5
LEN
55
2
KIM
48
10
ABT
48
-2
VRSK
89
5
GPS
63
4
TSN
30
3
ZION
44
3
PGR
69
5
BAX
35
2
TAP
31
2
BA
44
2
AAL
20
2
ES
33
-5
KSS
38
2
QCOM
82
3
CF
36
3
SYF
67
2
SRE
28
-5
TDC
55
-2
SWKS
60
-5
LEN
55
2
Financhill
Back

Aclaris Therapeutics Vs. Spyre Therapeutics Industry Stock Comparison

Sell
22

ACRS
Aclaris Therapeutics

Last Price:
1.13
Seasonality Move:
-8.1%
Sell
39

SYRE
Spyre Therapeutics

Last Price:
25.33
Seasonality Move:
49.76%
Sell
22
Aclaris Therapeutics (ACRS) is a Sell

Is Aclaris Therapeutics a Buy, Sell or Hold?

  • The current Aclaris Therapeutics [ACRS] share price is $1.13. The Score for ACRS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • ACRS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics a Buy, Sell or Hold?

  • The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACRS Stock Price Chart

What is Aclaris Therapeutics's stock price today?

  • The Aclaris Therapeutics share price today is $1.13
    The current trend is relatively stagnant and ACRS is experiencing slight selling pressure.

SYRE Stock Price Chart

What is Spyre Therapeutics's stock price today?

  • The Spyre Therapeutics share price today is $25.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.

ACRS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 50.43 Buy
Chaikin Money Flow: -214047 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.04 - 1.18) Buy
Bollinger Bands (100): (1.11 - 1.27) Sell

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.04 Sell
Relative Strength Index (14 RSI): 31.35 Sell
Chaikin Money Flow: -1780910 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.05 - 37.75) Sell
Bollinger Bands (100): (27.4 - 39.18) Sell

ACRS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.11 Buy
20-day SMA: 1.1 Buy
50-day SMA: 1.17 Sell
200-day SMA: 2.42 Sell
8-day EMA: 1.12 Buy
20-day EMA: 1.12 Buy
50-day EMA: 1.16 Sell
200-day EMA: 2.9 Sell

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.63 Sell
20-day SMA: 34.16 Sell
50-day SMA: 35.1 Sell
200-day SMA: 24.22 Buy
8-day EMA: 32.34 Sell
20-day EMA: 33.91 Sell
50-day EMA: 34.32 Sell
200-day EMA: 27.18 Sell

Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.04 per share, an increase this year of $0.86 per share, and an increase next year of $0.23 per share.

Spyre Therapeutics Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.

Aclaris Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):